quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:07·1499d
SECFiling
Arena Pharmaceuticals Inc. logo

SEC Form EFFECT filed by Arena Pharmaceuticals Inc.

ARNA· Arena Pharmaceuticals Inc.
Health Care
Original source

Companies

  • ARNA
    Arena Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Feb 9UpdateHC Wainwright & Co.$100.00
  • Dec 21UpdateCantor Fitzgerald$100.00
  • Dec 14UpdateJMP Securities-
  • Dec 14UpdateSVB Leerink$100.00
  • Dec 14UpdateRBC Capital$100.00
  • Dec 14UpdateCredit Suisse$100.00

Related

  • PR36d
    Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report
  • PR218d
    Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
  • PR386d
    Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director
  • SEC1494d
    SEC Form 15-12G filed by Arena Pharmaceuticals Inc.
  • SEC1499d
    SEC Form EFFECT filed by Arena Pharmaceuticals Inc.
  • SEC1499d
    SEC Form EFFECT filed by Arena Pharmaceuticals Inc.
  • SEC1499d
    SEC Form EFFECT filed by Arena Pharmaceuticals Inc.
  • INSIDER1504d
    SEC Form 4: Nova Tina Susan disposed of 20,843 shares, closing all direct ownership in the company
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022